Related Experiment Video
Updated: Aug 16, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Bidirectional changes in recorded pediatric asthma diagnoses with respiratory virus activity: A nationwide
Naomi Matsumoto1, Hisashi Ishida2, Shunsaku Hayase3
1Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Insights
Early-life respiratory infections may contribute to pediatric asthma. COVID-19 non-pharmaceutical interventions (NPIs) reduced respiratory viruses and asthma diagnoses, with asthma incidence rebounding as NPIs relaxed.
Area of Science:
- Pediatric respiratory health
- Epidemiology of infectious diseases
- Asthma research
Background:
- Early-life respiratory infections are linked to asthma development.
- The role of respiratory viruses in asthma onset versus unmasking susceptibility is unclear.
- The COVID-19 pandemic provided a natural experiment with non-pharmaceutical interventions (NPIs) suppressing and then allowing respiratory virus resurgence.
Purpose of the Study:
- To investigate the association between population-level changes in respiratory virus activity and pediatric asthma diagnoses.
- To examine the impact of COVID-19 NPIs and their relaxation on new pediatric asthma diagnoses.
- To assess the role of specific respiratory pathogens in pediatric asthma incidence.
Main Methods:
- A nationwide interrupted time-series study in Japan using health insurance claims data (approx. 99% population coverage).
- Segmented negative binomial regression analyzed monthly asthma diagnoses in children under 19 (Jan 2018-Mar 2024), with atopic dermatitis as a negative control.
- Analyses included age/sex stratification and ecological associations with specific pathogens.
Main Results:
- Newly recorded pediatric asthma diagnoses significantly declined after NPI implementation (IRR 0.511) and rebounded after NPI relaxation (IRR 1.395).
- Atopic dermatitis showed less pronounced changes, suggesting specificity to asthma.
- Rate differences were most significant in infants (0-1 years) post-NPI and school-aged children (5-9 years) post-NPI relaxation. Rhinovirus, RSV, influenza, and M. pneumoniae correlated with asthma diagnoses.
Conclusions:
- Pediatric asthma diagnoses exhibited bidirectional changes mirroring respiratory virus suppression and resurgence.
- Findings support a potential contributory role of respiratory infections in pediatric asthma development.
- Infants and school-aged children appear particularly susceptible to these effects.
Background:
Early-life respiratory infections are associated with subsequent asthma development; however, whether respiratory viruses contribute to asthma onset or merely unmask pre-existing susceptibility remains unclear. The COVID-19 pandemic's non-pharmaceutical interventions (NPIs) suppressed respiratory viruses, followed by their resurgence, offering a natural experiment. We examined whether these population-level changes in respiratory virus activity were associated with changes in newly recorded pediatric asthma diagnoses.
Methods:
We conducted a nationwide interrupted time-series study using Japan's National Database of Health Insurance Claims, covering approximately 99% of the population. Segmented negative binomial regression with two intervention points-NPI implementation (T1: March 2020) and COVID-19 reclassification (T2: May 2023)-was applied to monthly counts of newly recorded asthma diagnoses among children aged under 19 years (January 2018-March 2024), with atopic dermatitis as negative control. Age-stratified/sex-stratified analyses and exploratory ecological analyses of pathogen-specific associations were conducted.
Results:
Among 10,508,387 new asthma diagnoses, incidence declined significantly following NPI implementation (incidence rate ratio [IRR] 0.511, 95% confidence interval [CI] 0.422-0.620) and rebounded following NPI relaxation (IRR 1.395, 95% CI:1.120-1.737). Atopic dermatitis showed attenuated changes at both points. Rate differences were greatest in infants (0-1 years) at T1 and school-aged children (5-9 years) at T2. Rhinovirus, respiratory syncytial virus, influenza, and Mycoplasma pneumoniae, but not SARS-CoV-2, correlated with asthma diagnoses in ecological analyses.
Conclusions:
Newly recorded pediatric asthma diagnoses showed bidirectional changes that paralleled respiratory virus suppression and resurgence, compatible with a possible contributory role of respiratory infections, particularly among infants and school-aged children.
Related Concept Videos
Respiratory Syncytial Virus Disease
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction
Asthma-I: Introduction